The role of hyperuricemia and gout in kidney and cardiovascular disease.
about
Effect of allopurinol in chronic kidney disease progression and cardiovascular riskGout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort StudiesChronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study.The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.A new approach for noninvasive transdermal determination of blood uric acid levelsSwitching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney diseaseMechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.Non-invasive and transdermal measurement of blood uric acid level in human by electroporation and reverse iontophoresisNew and improved strategies for the treatment of goutFamilial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in TaiwanAllopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Uric acid as a mediator of diabetic nephropathy.Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled studyAllopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetesFamily history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi JewsHyperuricemia: An Early Marker for Severity of Illness in Sepsis.Silkworms can be used as an animal model to screen and evaluate gouty therapeutic drugsAssociation analysis between genetic variants in interleukin genes among different populations with hyperuricemia in Xinjiang Autonomous RegionElevated level of renal xanthine oxidase mRNA transcription after nephropathogenic infectious bronchitis virus infection in growing layers.Uric acid as a target of therapy in CKD.Higher Serum Uric Acid Is Associated with Higher Bone Mineral Density in Chinese Men with Type 2 Diabetes Mellitus.Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small moleculesUric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol studyAllopurinol for prevention of progression of kidney disease with hyperuricemia.Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysisDesign and synthesis of chalcone derivatives as potential non-purine xanthine oxidase inhibitors.Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?Low-dose aspirin use and recurrent gout attacks.An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.Dual-energy CT in gout - A review of current concepts and applications.Serum uric acid, protein intake and mortality in hemodialysis patients.Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong.A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia.The grey zone of Hyperuricemia in chronic kidney disease.Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article.Association of dietary patterns and hyperuricemia: a cross-sectional study of the Yi ethnic group in China.Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon.
P2860
Q24630327-686166CC-35D8-4DDC-95AC-C40CCDBC491DQ26800933-2D1AEA41-F7DA-48DE-9874-CEFF64F54591Q30930909-E9D37EC1-129A-4EF3-A4A6-1F54E5CAEEAAQ33634704-E05FCC74-8A48-4AB2-8D7A-797BB4AE8624Q33779697-9C9912DE-34A7-4CB6-9195-7310484D306FQ33857750-BACC9680-49DA-42C4-BC39-DB10103925A3Q34317722-F908D5E9-6C78-48FB-A600-5F49BC6C2E4EQ34322559-C5DC03E5-BD0D-4DEF-A06A-ECD3D9DB3735Q34440050-858474B0-CE9A-4B06-A6F9-BE8AF692444BQ35026692-2B314597-EDAE-4698-A131-55F840C7A138Q35048342-5D2FFC1C-51DD-464F-BC1B-FFE78373E201Q35121532-E1F9AA88-C4AF-4C35-ACED-7466F03D254FQ35393446-CBFFC4CB-3DE3-48B1-9F4F-7EF05E1CA629Q35620270-5F0F3F15-C78F-4663-A543-37EDE8EE9014Q35834966-2F76D4E7-2D6F-45BA-9178-8F65CD232B17Q35878999-C31AF622-BDDE-4A92-A94E-109DB421FB8DQ35886155-7A315A7F-8180-4C27-8849-EF19757C2EF3Q35941771-AA8CCF03-2B4F-485B-8333-03ECE9F7A153Q36305737-0536D86C-4151-42B4-898D-3CC66A7E871DQ36375514-B124B20B-0FB7-433E-80F4-FFD857641BAAQ36431295-9310FE4C-5659-48B1-99FA-FEF0435200F0Q36476464-C7E4A382-F83E-4841-99A8-BED14A35745CQ36679672-77177EAE-8BF2-481D-9C77-A2B443AC8084Q36729796-156F25B5-F17C-4CCE-A7BA-D75B6F1BED4BQ36988877-F5B1B044-A39F-4CCE-BC55-93413829660AQ37091149-35AD4C3B-607B-48F2-A08F-26F6BB9A0CADQ37240086-1BF848DA-8C70-476C-80F3-D11F98C2FAC2Q37338597-89C37AD3-307F-4DF5-A90B-149E28D200DBQ37350881-003A638D-882E-49A3-8416-F57E20A6944CQ37517681-55CDD30D-DA2E-45F2-A946-9C374B9B142EQ37641297-CE963BBD-D9B7-4829-9752-F56A3E762C64Q37707121-D4F62C4D-DB5D-433A-88C0-121AD8878C70Q40390732-FF4E3B61-7F61-49E3-8D30-EA917F68BC1AQ41209052-44A440B2-5FA5-432F-9E33-F0B127348941Q42016318-46B5CE45-1E6E-4E80-A2DA-2033131F6858Q42333924-7D68695D-7425-4C77-831E-DCF5093A41DAQ52622926-4A3AF83D-BC75-468B-94B3-F751E83FAB7EQ55003468-5817DE3A-C3CB-47D8-9805-E8E38A4C5D6CQ55564382-6BC02C44-47A7-4979-8A74-EEDA9ADFC0AD
P2860
The role of hyperuricemia and gout in kidney and cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@en
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@nl
type
label
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@en
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@nl
prefLabel
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@en
The role of hyperuricemia and gout in kidney and cardiovascular disease.
@nl
P1476
The role of hyperuricemia and gout in kidney and cardiovascular disease
@en
P2093
N Lawrence Edwards
P356
10.3949/CCJM.75.SUPPL_5.S13
P478
75 Suppl 5
P577
2008-07-01T00:00:00Z